Literature DB >> 8838150

Expression and localization of transforming growth factor-beta receptors type I and type II in the rat ventral prostate during regression.

I Y Kim1, H J Ahn, D J Zelner, L Park, J A Sensibar, C Lee.   

Abstract

Of the three ubiquitously expressed transforming growth factor-beta (TGF beta) receptors, only type I and type II receptors contain serine/threonine kinase activity and have a direct role in TGF beta signal transduction. In the prostate, it has been reported that the level of type III receptor expression increases transiently after castration. However, the relationship between the TGF beta signaling receptors, type I and type II, and androgen is currently unclear. Thus, in the present study, we made an initial attempt to elucidate the effect of androgen on type I and type II receptor expression in the rat ventral prostate by measuring the levels of messenger RNA (mRNA) and protein at specific time points after castration up to 10 days. Within 3 days after castration, an increase in type II receptor mRNA was observed in the prostate, and the level continued to rise until 7 days postcastration (approximately 8-fold increase). Between days 7-10 postcastration, no significant change in the level of type II receptor mRNA was observed. Testosterone administration immediately after castration abolished the induction of type II receptor mRNA during the same 10-day period. Western blot analysis performed for type II receptor showed a similar result, in that the level of type II receptor protein increased approximately 5-fold by day 10 postcastration. In a similar manner to the expression of type II receptor mRNA, the level of type I receptor mRNA increased steadily until day 7 postcastration (approximately 6-fold increase). Between days 7-10 postcastration, the level of type I receptor mRNA did not change significantly. As with type II receptor mRNA, the induction of type I receptor mRNA was suppressed when testosterone was administered immediately after castration. To localize the expression of TGF beta receptor type II, immunohistochemical studies were performed. The results of these studies demonstrated a preferential localization of type II receptor in the prostatic epithelial cells and an increased staining intensity for the receptor after castration. Taken together, these data indicate that TGF beta signaling receptors, type I and type II, are under negative androgenic regulation at the transcriptional level and that TGF beta may be an important regulator of a stromal-epithelial interaction in the rat ventral prostate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8838150     DOI: 10.1210/mend.10.1.8838150

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  6 in total

1.  DHT selectively reverses Smad3-mediated/TGF-beta-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cells.

Authors:  Kyung Song; Hui Wang; Tracy L Krebs; Bingcheng Wang; Thomas J Kelley; David Danielpour
Journal:  Mol Endocrinol       Date:  2010-08-25

2.  Transforming growth factor-beta 2 heterozygous mutant mice exhibit Cowper's gland hyperplasia and cystic dilations of the gland ducts (Cowper's syringoceles).

Authors:  Nicole Dünker; Gerhard Aumüller
Journal:  J Anat       Date:  2002-08       Impact factor: 2.610

3.  Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.

Authors:  Kyung Song; Hui Wang; Tracy L Krebs; Seong-Jin Kim; David Danielpour
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

4.  Increased CK5/CK8-positive intermediate cells with stromal smooth muscle cell atrophy in the mice lacking prostate epithelial androgen receptor.

Authors:  Yuanjie Niu; Juan Wang; Zhiqun Shang; Shu-Pin Huang; Chih-Rong Shyr; Shuyuan Yeh; Chawnshang Chang
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

5.  TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts.

Authors:  Sarah N Salm; Patricia E Burger; Sandra Coetzee; Ken Goto; David Moscatelli; E Lynette Wilson
Journal:  J Cell Biol       Date:  2005-06-27       Impact factor: 10.539

6.  Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer.

Authors:  S Mishra; J J Deng; P S Gowda; M K Rao; C-L Lin; C L Chen; T Huang; L-Z Sun
Journal:  Oncogene       Date:  2013-09-16       Impact factor: 9.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.